Interestingly, the genetic and pharmaceutical inhibition of HSP27 upregulated carnitine palmitoyltransferase I alpha (CPT1A), the rate-limiting enzyme of FAO, to sustain ovarian cancer cell survival during cisplatin treatment [5]. The gene discussed is HSPB1; the disease is ovarian carcinoma.